Which symptom after NMES should be reported as a potential adverse effect?

Study for the NMES Electrotherapy Test with our comprehensive quiz. Utilize flashcards and multiple choice questions, each accompanied by hints and explanations. Ensure you are fully prepared for your assessment!

Multiple Choice

Which symptom after NMES should be reported as a potential adverse effect?

Explanation:
When evaluating adverse effects after NMES, focus on signals that suggest nerve involvement rather than normal sensations. Persistent numbness or tingling after a treatment session indicates a potential issue with nerve function and should be reported for safety reasons. This isn’t a typical or expected post-treatment response and could reflect excessive intensity, improper electrode placement, or underlying nerve sensitivity that needs clinical assessment. In contrast, mild warmth at the skin, light tingling that resolves quickly, or short‑term muscle fatigue are common, transient experiences with NMES and usually don’t signal a safety problem. If these sensations disappear soon after the session, they don’t require immediate reporting, though any unusual or worsening symptoms should still be discussed with a clinician.

When evaluating adverse effects after NMES, focus on signals that suggest nerve involvement rather than normal sensations. Persistent numbness or tingling after a treatment session indicates a potential issue with nerve function and should be reported for safety reasons. This isn’t a typical or expected post-treatment response and could reflect excessive intensity, improper electrode placement, or underlying nerve sensitivity that needs clinical assessment.

In contrast, mild warmth at the skin, light tingling that resolves quickly, or short‑term muscle fatigue are common, transient experiences with NMES and usually don’t signal a safety problem. If these sensations disappear soon after the session, they don’t require immediate reporting, though any unusual or worsening symptoms should still be discussed with a clinician.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy